USE OF AN ANTIBODY AGAINST THE LAMININ RECEPTOR OR LAMININ RECEPTOR PRECURSOR FOR THE TREATMENT OR DIAGNOSIS OF SEVERAL CANCER TYPES

摘要

Use of an antibody against the laminin receptor or laminin receptor precursorfor the treatment of various cancers. Described is the use of a recombinantantibody comprising a binding site specific for an epitope of the lamininreceptor or laminin receptor precursor for the treatment or diagnosis ofvarious cancers, particularly B-CLL. Preferably, this antibody additionallycomprises a binding site for at least one particular cell surface antigen.